Whitwell Jennifer L, Jack Clifford R, Baker Matthew, Rademakers Rosa, Adamson Jennifer, Boeve Bradley F, Knopman David S, Parisi Joseph F, Petersen Ronald C, Dickson Dennis W, Hutton Michael L, Josephs Keith A
Division of Behavioral Neurology, Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Arch Neurol. 2007 Mar;64(3):371-6. doi: 10.1001/archneur.64.3.371.
Mutations in the progranulin gene (PGRN) have recently been identified as a cause of frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) in some families.
To determine whether there is a difference in the patterns of atrophy in FTLD-U cases with and without PGRN mutations.
Case-control study.
Brain bank of a tertiary care medical center. Patients Eight subjects who had screened positive for PGRN mutations (PGRN-positive) and who underwent volumetric magnetic resonance imaging were identified. Subjects were then matched by clinical diagnosis to a group of 8 subjects with a pathological diagnosis of FTLD-U who had screened negative for PGRN mutations (PGRN-negative). All subjects were then age-matched and sex-matched to a control subject.
Voxel-based morphometry was used to assess the patterns of gray matter atrophy in the PGRN-positive group compared with the PGRN-negative group and compared with controls.
The PGRN-positive group showed a widespread and severe pattern of gray matter loss predominantly affecting the frontal, temporal, and parietal lobes. The PGRN-negative group showed a less severe pattern of gray matter loss restricted mainly to the temporal and frontal lobes. On direct comparison, the PGRN-positive group showed greater gray matter loss in the frontal and parietal lobes compared with the PGRN-negative group.
Findings from this study suggest that PGRN mutations may be associated with a specific and severe pattern of cerebral atrophy in subjects with FTLD-U.
最近已确定,在一些家族中,原纤维蛋白基因(PGRN)突变是导致伴有泛素阳性包涵体的额颞叶痴呆(FTLD-U)的原因。
确定伴有和不伴有PGRN突变的FTLD-U病例的萎缩模式是否存在差异。
病例对照研究。
一家三级医疗中心的脑库。患者确定了8名PGRN突变筛查呈阳性(PGRN阳性)且接受了容积磁共振成像的受试者。然后根据临床诊断,将这些受试者与一组8名PGRN突变筛查呈阴性(PGRN阴性)且病理诊断为FTLD-U的受试者进行匹配。然后将所有受试者按照年龄和性别与一名对照受试者进行匹配。
采用基于体素的形态测量法,评估PGRN阳性组与PGRN阴性组以及与对照组相比的灰质萎缩模式。
PGRN阳性组显示广泛且严重的灰质丢失模式,主要影响额叶、颞叶和顶叶。PGRN阴性组显示较轻的灰质丢失模式,主要局限于颞叶和额叶。直接比较显示,与PGRN阴性组相比,PGRN阳性组在额叶和顶叶的灰质丢失更多。
本研究结果表明,PGRN突变可能与FTLD-U患者特定且严重的脑萎缩模式相关。